Liminatus Pharma Stock (NASDAQ:LIMN)
Previous Close
$20.31
52W Range
$4.40 - $26.68
50D Avg
$9.67
200D Avg
$9.67
Market Cap
$375.13M
Avg Vol (3M)
$357.75K
Beta
0.17
Div Yield
-
LIMN Company Profile
Liminatus Pharma, Inc. operates as a clinical-stage immuno-oncology company that develops novel cancer therapies. The company is based in LA Palma, California.